Comparison of prognostic scores and surgical approaches to treat spinal metastatic tumors: A review of 57 cases

Yılmazlar, Selçuk; Doğan, Selami; Caner, Başak; Turkkan, Alper; Bekâr, Ahmet; Korfalı, Ender

doi:10.1186/1749-799x-3-37

Cited by 17 publications

(16 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of the 46 patients diagnosed with metastatic spinal cord compression, no apparent change in incidence was detected over the decade. A preponderance of males over females was found among our patients; males numbering 63.49% whereas there were 36.51% females, which was in concordance with the results of Selcuk Yilmazlar, et al [13], who had observed that 63.1% patients were males and 36.9% were females. These results were also in conformity with results derived by Loblaw, et al [1] who reported 57% of their patients were men.…”

Section: Discussionsupporting

confidence: 81%

“…Commonest age group of patients in this study was ≥60 years. Mean age of males was 48.4 years and that of females was 42.26 years, which corroborated well with the findings of Selcuk Yilmazlar, et al [13], who in their study population noted a mean age of 48.9 ± 16.3 years. Median age of MSCC patients in this study was 49 years.…”

Section: Discussionsupporting

confidence: 81%

“…Selcuk Yilmazlar, et al [13] had noted that the metastasis was located in the cervical region in 7% patients, the thoracic region in 49.2% patients, the lumbar region in 28% patients, the thoracolumbar junction in 10.5% patients and the cervico-thoracic junction in 3.5%. Sundaresan and Galicich [17] report the sites of involvement included the cervical region in 13%, the thoracic region in 68% and the lumbar region in 20%.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Metastatic Spinal Cord Compression (MSCC) —The Evolving Story from Kashmir

Mir¹,

Bhat²,

Reshi³

et al. 2014

OJMN

View full text Add to dashboard Cite

Aim: To know the demographics of the patients most commonly involved by metastatic cord compression in Kashmir and to find the commonest primary organ to metastasize to spine causing cord compression. Methods: A hospital-based 10-year retro-prospective study was carried out in the Department of Neurosurgery of Sher-i-Kashmir Institute of Medical Sciences, Soura from July 2002 to June 2012, which is the premier tertiary care institute of the Kashmir valley. Patients were evaluated for metastatic spinal cord compression based on a standard proforma and specialized investigations were carried out and were deemed necessary by the concerned neurosurgical unit. Results: The commonest primary malignancy to metastasize to the spinal column in our study was Non-Hodgkin's lymphoma, followed in turn by metastatic squamous cell carcinoma lung, metastatic intraductal carcinoma breast and metastatic adenocarcinoma prostate. Predominantly dorsal spine was the commonest region of spine involved by MSCC. Conclusion: Metastatic spinal cord compression is coming up in a big way. As the long-term cancer survivors increase due to multi-modality treatment protocols aimed at treating cancers and prolonging survival, there will be a proportionate increase in the number of patients who will potentially land up in metastatic spinal cord compression.

show abstract

Section: Discussionsupporting

confidence: 81%

Section: Discussionsupporting

confidence: 81%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Metastatic Spinal Cord Compression (MSCC) —The Evolving Story from Kashmir

Mir¹,

Bhat²,

Reshi³

et al. 2014

OJMN

View full text Add to dashboard Cite

show abstract

“…However, Choi et al [10] on behalf of the Global Spine Tumor Study Group have included myeloma and lymphoma to be one of the commonest causes of metastatic spinal cancer. Yilmazlar et al [11], in their study, have also included myeloma and lymphoma cases in their comparison of prognostic scores in metastatic spinal cancer groups. In our study, 73.3 % of patients with myeloma survived more than 12 months.…”

Section: Discussionmentioning

confidence: 99%

A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer

et al. 2012

View full text Add to dashboard Cite

Purpose Predicted survival of a patient is the most important parameter that helps to guide the treatment of a patient with metastatic spinal cancer. We aimed to investigate the reliability of modified Tokuhashi score in the decisionmaking process in patients with metastatic spinal cancer. Methods We performed a review of our prospectively collected Metastatic Cancer Database over a period of 4 years (2007)(2008)(2009)(2010). Ninety consecutive patients who were treated for metastatic spinal cancer were enrolled. Data review included demographic details, source of primary cancer, duration of symptoms, location of metastases, calculated Karnofsky's performance status, and calculated survival based on modified Tokuhashi score. We divided the patients into 3 groups. Group A included patients with expected survival less than 6 months. Group B included patients with expected survival between 6 and 12 months. Group C included patients whose expected survival was more than 12 months. We compared the calculated expected survival to the actual survival in all three groups with all patients following up to a minimum of 1 year or until death. Statistical analysis was done by Chi-square test and the Fisher Exact test.Results The survival prediction in group C was significantly accurate in 80.9 % patients (P = 0.027). However, in groups A and B, only 36.1 and 9.1 % patients survived, respectively, as per predicted. (P [ 0.05). Conclusions We can conclude from this study that, when used alone, modified Tokuhashi score may not be a reliable tool to predict survival in all patient groups.

show abstract

“…Table 3 reports predicted and observed survivals. Observed median survival in the 0-8, 9-11, and 12-15 Tokuhashi score groups was 5 months (95% CI, 3-6), 10 months (95% CI, [8][9][10][11][12][13][14][15][16][17][18][19], and 36 months (95% CI, 30-54), respectively. Fig.…”

Section: Survival Predicted By the Tokuhashi Score And Observed Survivalmentioning

confidence: 99%

Tokuhashi score and other prognostic factors in 260 patients with surgery for vertebral metastases

Eap¹,

Tardieux²,

Goasgen³

et al. 2015

Orthopaedics & Traumatology: Surgery & Research

View full text Add to dashboard Cite

show abstract

Comparison of prognostic scores and surgical approaches to treat spinal metastatic tumors: A review of 57 cases

Cited by 17 publications

References 14 publications

Metastatic Spinal Cord Compression (MSCC) —The Evolving Story from Kashmir

Metastatic Spinal Cord Compression (MSCC) —The Evolving Story from Kashmir

A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer

Tokuhashi score and other prognostic factors in 260 patients with surgery for vertebral metastases

Contact Info

Product

Resources

About